Joint-trajectories of clinical severity, social functioning and cannabis use in first-episode psychosis: A 5-year longitudinal study in 2 urban early intervention services

Giuseppe D'Andrea,Clairélaine Ouellet-Plamondon,Marie Villeneuve,Jai L Shah,Srividya N Iyer,Amal Abdel-Baki
DOI: https://doi.org/10.1016/j.psychres.2024.116184
2024-09-11
Abstract:Cannabis use is associated with increased psychosis incidence alongside worse outcomes. The role of cannabis may be complex, vary across patients and over time. Yet, few have examined the longer-term trajectories of cannabis use, symptoms and functioning and their inter-relationships. We conducted a 5-year longitudinal study to estimate joint-trajectories of clinical severity, social functioning, and cannabis use via group-based multi-trajectory modelling on a sample of 395 incident FEP cases. Associations of trajectories with socio-demographic and clinical factors were tested using multinomial regression. The best-fitting model identified 5 joint-trajectories. A first group (N = 93,23.7 %) presented only marginal improvement despite not using cannabis, while a second with no cannabis use and a third group with low-decreasing use showed clinical amelioration. Among those with baseline harmful cannabis use, a fourth group progressively discontinued use and improved clinically (N = 78,19.9 %). A fifth group with continued use did not significantly improve over follow-up (N = 74,18.8 %), and also had the highest odds of homelessness (OR = 22.5,95 %CI = 6.25-81.1) and childhood adversities (OR = 2.25,95 %CI = 1.71-2.97). There is substantial heterogeneity in the joint-trajectories of cannabis use and FEP outcomes. Our findings support the need for intervention aimed at cannabis reduction among heavy users. Multi-disciplinary, trauma-informed interventions may benefit those with persistent cannabis use, given its associations with childhood and social adversity.
What problem does this paper attempt to address?